Isolation of primitive endoderm, mesoderm, vascular endothelial and trophoblast progenitors from human pluripotent stem cells

Drukker, Micha; Tang, Chad; Ardehali, Reza; Rinkevich, Yuval; Seita, Jun; Lee, Andrew S; Mosley, Adriane R; Weissman, Irving L; Soen, Yoav
June 2012
Nature Biotechnology;Jun2012, Vol. 30 Issue 6, p531
Academic Journal
To identify early populations of committed progenitors derived from human embryonic stem cells (hESCs), we screened self-renewing, BMP4-treated and retinoic acid-treated cultures with >400 antibodies recognizing cell-surface antigens. Sorting of >30 subpopulations followed by transcriptional analysis of developmental genes identified four distinct candidate progenitor groups. Subsets detected in self-renewing cultures, including CXCR4+ cells, expressed primitive endoderm genes. Expression of Cxcr4 in primitive endoderm was confirmed in visceral endoderm of mouse embryos. BMP4-induced progenitors exhibited gene signatures of mesoderm, trophoblast and vascular endothelium, suggesting correspondence to gastrulation-stage primitive streak, chorion and allantois precursors, respectively. Functional studies in vitro and in vivo confirmed that ROR2+ cells produce mesoderm progeny, APA+ cells generate syncytiotrophoblasts and CD87+ cells give rise to vasculature. The same progenitor classes emerged during the differentiation of human induced pluripotent stem cells (hiPSCs). These markers and progenitors provide tools for purifying human tissue-regenerating progenitors and for studying the commitment of pluripotent stem cells to lineage progenitors.


Related Articles

  • Efficient and Directive Generation of Two Distinct Endoderm Lineages from Human ESCs and iPSCs by Differentiation Stage-Specific SOX17 Transduction. Takayama, Kazuo; Inamura, Mitsuru; Kawabata, Kenji; Tashiro, Katsuhisa; Katayama, Kazufumi; Sakurai, Fuminori; Hayakawa, Takao; Furue, Miho Kusuda; Mizuguchi, Hiroyuki // PLoS ONE;2011, Vol. 6 Issue 7, p1 

    The establishment of methods for directive differentiation from human embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) is important for regenerative medicine. Although Sry-related HMG box 17 (SOX17) overexpression in ESCs leads to differentiation of either extraembryonic or...

  • A HCN4+ cardiomyogenic progenitor derived from the first heart field and human pluripotent stem cells. Später, Daniela; Abramczuk, Monika K.; Buac, Kristina; Zangi, Lior; Stachel, Maxine W.; Clarke, Jonathan; Sahara, Makoto; Ludwig, Andreas; Chien, Kenneth R. // Nature Cell Biology;Sep2013, Vol. 15 Issue 9, p1098 

    Most of the mammalian heart is formed from mesodermal progenitors in the first and second heart fields (FHF and SHF), whereby the FHF gives rise to the left ventricle and parts of the atria and the SHF to the right ventricle, outflow tract and parts of the atria. Whereas SHF progenitors have...

  • Modulation of FOXD3 Activity in Human Embryonic Stem Cells Directs Pluripotency and Paraxial Mesoderm Fates. Arduini, Brigitte L.; Brivanlou, Ali H. // Stem Cells (Wiley-Blackwell);Oct2012, Vol. 30 Issue 10, p2188 

    Transcription factor Foxd3 has been described in model systems as a key member of the pluripotency network in mice as well as being involved in the formation of many critical vertebrate cell types in vivo. Yet virtually nothing is known about roles of FOXD3 in human development and conflicting...

  • Generating Hypoimmunogenic Human Embryonic Stem Cells by the Disruption of Beta 2-Microglobulin. Lu, Pengfei; Chen, Jijun; He, Lixiazi; Ren, Jiangtao; Chen, Haide; Rao, Lingjun; Zhuang, Qinggang; Li, Hui; Li, Lei; Bao, Lei; He, Ji; Zhang, Wei; Zhu, Faming; Cui, Chun; Xiao, Lei // Stem Cell Reviews & Reports;Dec2013, Vol. 9 Issue 6, p806 

    Immune rejection hinders the application of human embryonic stem cells (hESCs) in transplantation therapy. Human leukocyte antigens (HLAs) on the cell surface are the major cause of graft rejection. In this study, we generated HLA class I-deficient hESCs via disruption of beta 2-microglobulin...

  • Stem Cell Mutations Explored. Luntz, Stephen // Australasian Science;Mar2012, Vol. 33 Issue 2, p5 

    The article discusses a research study on pluripotent stem cells which found that there are higher mutation rates in the induced pluripotent stem cell (iPS) lines as compared with the human embryonic stem (HES) cell lines.

  • Alternative Routes to Induce Naïve Pluripotency in Human Embryonic Stem Cells. Duggal, Galbha; Warrier, Sharat; Ghimire, Sabitri; Broekaert, Dorien; Van der Jeught, Margot; Lierman, Sylvie; Deroo, Tom; Peelman, Luc; Van Soom, Ann; Cornelissen, Ria; Menten, Björn; Mestdagh, Pieter; Vandesompele, Jo; Roost, Matthias; Slieker, Roderick C.; Heijmans, Bastiaan T.; Deforce, Dieter; De Sutter, Petra; De Sousa Lopes, Susana Chuva; Heindryckx, Björn // Stem Cells (Wiley-Blackwell);Sep2015, Vol. 33 Issue 9, p2686 

    Human embryonic stem cells (hESCs) closely resemble mouse epiblast stem cells exhibiting primed pluripotency unlike mouse ESCs (mESCs), which acquire a naïve pluripotent state. Efforts have been made to trigger naïve pluripotency in hESCs for subsequent unbiased lineage-specific...

  • Pushing the Reset Button: Chemical-Induced Conversion of Amniotic Fluid Stem Cells Into a Pluripotent State. Diecke, Sebastian; Wu, Joseph C // Molecular Therapy;Oct2012, Vol. 20 Issue 10, p1839 

    The authors discuss the study on the factor-free derivation of a pluripotent cell type using a c-Kit+ subpopulation of human amniotic fluid cells. The authors say that the potential of human embryonic stem cells (hESC) to differentiate into any cell type of the human body has raised the hope on...

  • Putting induced pluripotent stem cells to the test. Vallier, Ludovic // Nature Biotechnology;Nov2015, Vol. 33 Issue 11, p1145 

    The article focuses on the sustainability of Human induced pluripotent stem cells (hiPSCs) for supporting clinical applications. Topics discussed include new possibilities for personalized cell therapy after the discovery that human somatic cell can be reprogrammed into a pluripotent stem cell,...

  • An in vivo model of human small intestine using pluripotent stem cells. Watson, Carey L; Helmrath, Michael A; Mahe, Maxime M; Sundaram, Nambirajan; Poling, Holly M; Múnera, Jorge; Schweitzer, Jamie I; Mayhew, Christopher N; Wells, James M; Howell, Jonathan C; Vallance, Jefferson E; Sun, Ying; Grabowski, Gregory; Finkbeiner, Stacy R; Spence, Jason R; Shroyer, Noah F // Nature Medicine;Nov2014, Vol. 20 Issue 11, p1310 

    Differentiation of human pluripotent stem cells (hPSCs) into organ-specific subtypes offers an exciting avenue for the study of embryonic development and disease processes, for pharmacologic studies and as a potential resource for therapeutic transplant. To date, limited in vivo models exist for...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics